Research In Brief
This article was originally published in The Gray Sheet
Data and trial updates in cardiology, oncology and more.
You may also be interested in...
Overdiagnosis and overtreatment of prostate cancers that result from screening with prostate-specific antigen tests highlight the need for research on new diagnostics technologies, suggests a new draft statement from the U.S. Preventive Services Task Force.
Boston Scientific is entering the transcatheter aortic heart valve race in earnest with its deal, announced Nov. 19, to purchase the remainder of start-up firm Sadra Medical for up to $450 million.
Annual screening of current and former heavy smokers with computed tomography can reduce their risk of dying from lung cancer by about 20%, according to a large National Cancer Institute-backed study.